When Tris Dyson lost the use of his thumb in 2022, he had no idea it was the first sign of motor neurone disease (ALS). Just 44 years old, newly engaged, and a new father, his world shifted overnight. But instead of slowing down, Tris leaned into his life’s work—fueling global scientific breakthroughs through prize-driven innovation.
In this episode, Tris shares how he’s turning a devastating diagnosis into a mission to spark the next major medical breakthrough. As the managing director behind the $10 million dollar Longitude Prize for ALS, he’s channeling urgency, optimism, and innovation into solving one of the most brutal neurological diseases on the planet. This conversation is about resilience, purpose, and why Tris still believes the clock can be beaten.
Podden och tillhörande omslagsbild på den här sidan tillhör
Sam Kleckley. Innehållet i podden är skapat av Sam Kleckley och inte av,
eller tillsammans med, Poddtoppen.
